Epithelial cell PPARγ contributes to normal lung maturation
暂无分享,去创建一个
Thomas J. Mariani | Larry W. Tsai | Frank J. Gonzalez | Soumyaroop Bhattacharya | S. Bhattacharya | T. Mariani | E. Ingenito | S. Shapiro | F. Gonzalez | S. Srisuma | Edward P. Ingenito | Sorachai Srisuma | Steven D. Shapiro | Dawn M. Simon | Meltem C. Arikan | L. Tsai | M. Arikan | D. Simon | S. Shapiro | S. Bhattacharya
[1] T. Mazzone,et al. Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression. , 2004, The Journal of biological chemistry.
[2] Philippe Soriano. Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.
[3] M. Post,et al. Genetic Control of Lung Development , 2003, Neonatology.
[4] T. Mariani,et al. Induction of macrophage elastase (MMP‐12) gene expression by statins , 2005, Journal of cellular physiology.
[5] B. Spiegelman,et al. Hic-5 regulates an epithelial program mediated by PPARgamma. , 2005, Genes & development.
[6] Philippe Gosset,et al. Peroxisome proliferator‐activated receptor γ activators affect the maturation of human monocyte‐derived dendritic cells , 2001 .
[7] M. Belvisi,et al. PPAR‐γ agonists as therapy for diseases involving airway neutrophilia , 2004, European Respiratory Journal.
[8] T. Hla,et al. The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses1 , 2000, The Journal of Immunology.
[9] J. Auwerx,et al. Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil Activation , 2003, The Journal of experimental medicine.
[10] R. Phipps,et al. PPAR‐γ‐Mediated Regulation of Normal and Malignant B Lineage Cells , 2000 .
[11] M. Yacoub,et al. PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. , 2004, The European respiratory journal.
[12] M. Aubier,et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. , 2001, American journal of respiratory and critical care medicine.
[13] J. Berger,et al. The mechanisms of action of PPARs. , 2002, Annual review of medicine.
[14] K. Lutchen,et al. Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling. , 2005, Journal of applied physiology.
[15] B. Spiegelman,et al. Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.
[16] B Staels,et al. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. , 2001, European journal of immunology.
[17] R. Nemenoff,et al. Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC) , 2005, Oncogene.
[18] K. Chien,et al. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development , 1999 .
[19] M. Alegret,et al. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. , 2003, Metabolism: clinical and experimental.
[20] R. Evans,et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. , 1999, Molecular cell.
[21] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[22] R. Nemenoff,et al. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). , 2005, Oncogene.
[23] X. Dai,et al. Peroxisome Proliferator–Activated Receptor- γ Regulates Airway Epithelial Cell Activation , 2001 .
[24] E. Mazzon,et al. Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury , 2005, European Respiratory Journal.
[25] D. Dombrowicz,et al. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. , 2004, The Journal of allergy and clinical immunology.
[26] H. Hammad,et al. Copyright © American Society for Investigative Pathology Activation of Peroxisome Proliferator-Activated Receptor- � in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma , 2022 .
[27] C. Glass,et al. Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux , 2002, Molecular and Cellular Biology.
[28] Steven D Shapiro,et al. Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. , 2002, American journal of respiratory cell and molecular biology.
[29] T. Welte,et al. Expression of cathepsins B, H, K, L, and S during human fetal lung development , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[30] M. Fu,et al. Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity , 2004 .
[31] R. Phipps,et al. PPAR-gamma-mediated regulation of normal and malignant B lineage cells. , 2000, Annals of the New York Academy of Sciences.
[32] H. Du,et al. Neutral lipids and peroxisome proliferator-activated receptor-{gamma} control pulmonary gene expression and inflammation-triggered pathogenesis in lysosomal acid lipase knockout mice. , 2005, The American journal of pathology.
[33] H. Du,et al. Peroxisome Proliferator-activated Receptor γ and Ligands Inhibit Surfactant Protein B Gene Expression in the Lung* , 2003, Journal of Biological Chemistry.
[34] B. Spiegelman,et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[36] Yan Xu,et al. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[37] T. Mazzone,et al. Divergent Effects of Peroxisome Proliferator-activated Receptor γ Agonists and Tumor Necrosis Factor α on Adipocyte ApoE Expression* , 2004, Journal of Biological Chemistry.
[38] H. Hammad,et al. Activation of Peroxisome Proliferator-Activated Receptor-γ in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma , 2004 .
[39] Michiie Sakamoto,et al. Altered Expression of the ERM Proteins in Lung Adenocarcinoma , 2000, Laboratory Investigation.
[40] S. Brody,et al. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[41] Dallas Jones,et al. Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.
[42] D. Gozal,et al. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. , 1998, American journal of respiratory cell and molecular biology.
[43] Samuel Singer,et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ , 1998, Nature Medicine.
[44] X. Dai,et al. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. , 2001, American journal of respiratory cell and molecular biology.
[45] P. Shankaranarayanan,et al. IL-4 Induces Apoptosis in A549 Lung Adenocarcinoma Cells: Evidence for the Pivotal Role of 15-Hydroxyeicosatetraenoic Acid Binding to Activated Peroxisome Proliferator-Activated Receptor γ Transcription Factor1 , 2003, The Journal of Immunology.
[46] T. Mariani,et al. Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-alpha and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury. , 1998, Molecular biology of the cell.
[47] J. Shannon,et al. Epithelial-mesenchymal interactions in the developing lung. , 2004, Annual review of physiology.